We are live on
!
Find out more
CCM
Chiron Capital Management Portfolio holdings
AUM
$111M
This Fund
S&P 500
This Quarter
Est. Return
-6.57%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$137M
AUM Growth
+$17.1M
(+14%)
Cap. Flow
+$25.1M
Cap. Flow
% of AUM
18.33%
Top 10 Holdings %
Top 10 Hldgs %
53.07%
Holding
103
New
24
Increased
39
Reduced
26
Closed
2
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Biotech ETF
XBI
|
+$3.99M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$3.29M |
| 3 |
AT&T
T
|
+$3.04M |
| 4 |
Lockheed Martin
LMT
|
+$1.56M |
| 5 |
Uber
UBER
|
+$1.46M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$3.1M |
| 2 |
Gilead Sciences
GILD
|
+$1.72M |
| 3 |
SPLK
Splunk Inc
SPLK
|
+$1.28M |
| 4 |
Raymond James Financial
RJF
|
+$403K |
| 5 |
Johnson & Johnson
JNJ
|
+$214K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 43.41% |
| 2 | Technology | 9.71% |
| 3 | Energy | 6.58% |
| 4 | Communication Services | 6.2% |
| 5 | Consumer Staples | 5.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Sundial Growers
SNDL
$315M
| $8K | 0.01% |
+1,133
| New | +$8.85K |
|
|
102
Johnson & Johnson
JNJ
$619B
| – | – |
-1,300
| Closed | -$214K |
|
103
Senseonics Holdings Inc
SENS
$270M
| – | – |
-629
| Closed | -$48K |
|
Similar funds
EGP
WWMP
HCM
NIM
SPWM
JE
VP
IWP
Chiron Capital Management's Q3 2021 Portfolio in Review
As of Q3 2021, Chiron Capital Management held 103 positions worth $137M, up 14% from $120M the previous quarter. Its ten largest holdings account for 53% of the portfolio.
Chiron Capital Management deployed $25.1M of net new capital in Q3 2021, opening 24 new positions and adding to 39 existing holdings. Its largest new stake was Lockheed Martin: 4,310 shares worth $1.49M.
By sector, the portfolio is most concentrated in Healthcare at 43% of assets, down from 54% a quarter earlier, followed by Technology and Energy.
On the sell side, the largest reduction was Pfizer, an estimated $3.1M trimmed.
- Chiron Capital Management's largest Q3 2021 buy was Lockheed Martin: 4,310 shares worth $1.49M.
- Chiron Capital Management added most to State Street SPDR S&P Biotech ETF in Q3 2021, an estimated $3.99M increase.
- Chiron Capital Management's biggest Q3 2021 reduction was Pfizer, cutting an estimated $3.1M.
- Chiron Capital Management fully exited Johnson & Johnson in Q3 2021, selling an estimated $214K.
- Chiron Capital Management's ten largest holdings make up 53% of its $137M portfolio in Q3 2021.
- Chiron Capital Management opened 24 new positions and closed 2 in Q3 2021.
- Chiron Capital Management's portfolio value rose 14% quarter-over-quarter to $137M.
Based on Chiron Capital Management's 13F filing for Q3 2021, filed 21 Oct 2021.